Some monitors saw community transmission taking place in the London area as of mid-May,[9] but it has been suggested that cases were already spreading in Europe in the previous months.
[14] On 6 August, a third case of imported mpox was reported, involving a man in his 20s who had returned to Taiwan from the United States.
[15] The fourth imported case, reported on 9 October, involved a man in his 40s who had visited Canada, and developed symptoms in the United States.
[20] In February 2024, Taiwan's Ministry of Health and Welfare formally changed the Mandarin name of the disease from monkeypox (猴痘) to mpox (M痘).
This mirrored a change in the English-language name of the disease, originally proposed by the World Health Organization (WHO) on 28 November 2022.
[25] Later that month, health minister Chen Shih-chung stated that Taiwan was not yet planning to purchase a mpox vaccine.
[26] As the global outbreak spread, Taiwan designated mpox as a category 2 communicable disease on 23 June.
[30] On 2 July, the CDC announced that they are planning to receive third-generation smallpox vaccines and antiviral drugs in late 2022.
[31] On 24 July, the CDC announced that they signed a contract to purchase medication to treat mpox patients, and that a shipment will arrive in August at the earliest.